General Information
Revision date
2016-07-25
Product name
Sodium Iodide I-131 Capsules Therapeutic
Product Synonyms
Sodium
1.2.1 Relevant identified uses
treatment of hyperthyroidism and thyroid carcinomas that take up iodine
1.2.2. Uses advised against
Recommended restrictions
Manufacturer Name
Mallinckrodt Nuclear Medicine LLC
Emergency telephone
314-654-1600
Icons in SDS
Company Information
company name
Mallinckrodt Nuclear Medicine LLC
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
identification
Physical hazards
Physical hazards Not classified.
Health hazards
Health hazards Germ cell mutagenicity Category 1B Carcinogenicity Category 1B Reproductive toxicity Category 1B Reproductive toxicity Effects on or via lactation Specific target organ toxicity, single exposure Category 1 (Thyroid) Specific target organ toxicity, repeated Category 1 (Thyroid, Bone marrow, Heart, exposure Blood)
Environmental hazards
Environmental hazards Not classified. Label
2.2 Label elements
elements
Signal word
Signal word Danger
Hazard statements
Hazard statement May cause genetic defects. May cause cancer. May damage fertility or the unborn child. May cause harm to breast-fed children. Causes damage to organs (Thyroid). Causes damage to organs (Thyroid, Bone marrow, Heart, Blood) through prolonged or repeated exposure. RADIOACTIVE MATERIAL. HANDLE ACCORDING TO ALL FEDERAL AND STATE REGULATIONS GOVERNING THE USE OF RADIOACTIVE MATERIAL Precautionary
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe mist or vapor. Do not eat, drink or smoke when using this product. Avoid contact during pregnancy and while nursing. Wear protective gloves/protective clothing/eye protection/face protection. Wash thoroughly after handling.
Response
If exposed or concerned: Get medical advice/attention.
Storage
Store locked up. Store away from incompatible materials.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Other
2.3 Other hazards
None known.
Additional information
Supplemental information Unwanted radiation exposure can occur from handling and administration of radiopharmaceuticals or from contaminated waste products, including urine and feces. Follow safe administration instructions to minimize unnecessary radiation exposure to patients and health care workers. Radioactive materials in Canada are not subject to HPR regulations. The Canadian Nuclear Safety Commission (CNSC) is the Federal agency responsible for protecting the health and safety of the public and the environment by licensing and regulating the civilian uses of the radioactive materials. CAUTION! RADIOACTIVE MATERIAL. Read Package Insert prior to use. Promptly remove any contamination from the skin, eyes, or clothing. Radioactive drugs must be handled by qualified personnel in conformity with regulations appropriate to the government agency authorized to license the use of this radionuclide. The vial containing the drug should be kept within its container or within heavier shielding. Avoid contact with the radioactive contents which would cause unnecessary exposure to radiation. 3. 3. 3. 3. Composition/information